LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
Learn about the association of recreational drugs and rheumatic conditions including:
- Identify the clinical features of hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), and differentiate them from other conditions that present with similar symptoms.
- Explain the pathophysiology and immunology of HLH/MAS, and discuss the role of immune dysregulation in the development of these conditions.
- Formulate an appropriate diagnostic and treatment plan for patients with HLH/MAS, considering underlying triggers, immunosuppressive and biologic therapies, and supportive care.
Session date:
02/28/2023 - 9:30am to 10:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Ryan Mitacek, M.D.